Funder: National Institutes of Health

Due Dates: October 1, 2025 (Letter of Intent) | October 31, 2025 (New Applications) | June 1, 2026 (Letter of Intent) | July 1, 2026 (Renewal/Resubmission/Revision)

Funding Amounts: ~$2.4M/year total for 2–4 awards; budgets not limited but must reflect actual needs; up to 5 years/project.

Summary: Supports facilities to scale up production and distribution of brain cell type-specific access reagents for broad neuroscience research use.

Key Information: Clinical trials are not allowed; applicants must address all four required facility functions and include milestones/timeline.